Quantum Optimization and AI to Develop Alzheimer’s Drugs
by Brian Wang from NextBigFuture.com on (#792AA)
INmune Bio (Nasdaq: INMB) and Quantum Computing Inc. (Nasdaq: QUBT) announced they are working togther to run INmune Bio's clinical and preclinical data on XPro (XPro1595) through QCi's Dirac-3S quantum optimization machine, combined with AI and conventional analytics. XPro is INmune Bio's investigational dominant-negative TNF drug designed to selectively block soluble TNF (a driver of ...